Viewing Study NCT04457869


Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2026-06-28 @ 8:17 PM
Study NCT ID: NCT04457869
Status: UNKNOWN
Last Update Posted: 2020-10-22
First Post: 2020-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Central Nervous System Lymphoma View
None Secondary Central Nervous System Lymphoma View
Keywords: